Liminatus Pharma, Inc.
LIMNNASDAQHealthcareBiotechnology
As of Oct 23, 2026 close
- Market cap
- $2.85M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.16$17.92
- Volume (live)
- -
- Avg. volume (3M)
- 26.66K
Liminatus Pharma (LIMN) Stock Price & Financial Analysis
Liminatus Pharma Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $2.91 - $3.17 |
|---|---|
| 52-Week High | $17.92 |
| 52-Week Low | $0.16 |
| Open | $3.10 |
| Volume (last close) | 20.67K |
| Average Volume (3M) | 26.66K |
| 50-Day MA | $4.19 |
|---|---|
| 200-Day MA | $3.01 |
| 1-Year Change | +159.17% |
| Market Cap | 2.85M |
|---|---|
| Shares Outstanding | 967.97K |
| Price to Book (P/B) | 9.47 |
| EV/EBITDA | -0.12 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
Liminatus Pharma at a Glance
As of the Oct 23, 2026 close, Liminatus Pharma (LIMN) has a market capitalization of $2.85M.
As of its latest reported balance sheet, it holds $3.02M in cash and securities against $1.44M of debt, a net cash position of $1.57M.
Liminatus Pharma does not currently pay a dividend.
The share price is up 159.2% over the past year. At $2.94 (the Oct 23, 2026 close) it sits within its 52-week range of $0.16 to $17.91, below its 200-day moving average of $3.01.
Frequently Asked Questions About Liminatus Pharma
What is the current stock price for LIMN?
As of the Oct 23, 2026 close, LIMN stock trades at $2.94. The 52-week range is $0.16–$17.92, with a day range of $2.90–$3.17.
What is the P/E ratio for LIMN?
The P/E ratio (Price-to-Earnings) for LIMN is shown in the Key Statistics section. This valuation metric helps compare Liminatus Pharma, Inc. to industry peers.
Does LIMN pay dividends?
Liminatus Pharma does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for LIMN?
Analyst ratings and recommendations for LIMN are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of LIMN?
As of the Oct 23, 2026 close, Liminatus Pharma's market capitalization is $2.8M, classifying it as a micro-cap company. Liminatus Pharma operates in the Healthcare sector within the Biotechnology industry.